Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Amgen has announced plans to expand its US-based manufacturing footprint by building a new final product advanced assembly and packaging plant near Columbus, Ohio. Plant construction is slated to begin in the fall of 2021, with $365 million of...

GlaxoSmithKline (GSK) CEO Emma Walmsley outlined the company’s  growth strategy at an investor event earlier this week (June 23, 2021), which includes a revenue target of more than £33 billion ($46 billion) for its bio/pharmaceutical and...

The latest on COVID-19 vaccines/drugs, manufacturing, and testing from AstraZeneca, Gilead, GSK, Vir, Novavax, Celltrion, and Thermo Fisher Scientific. Manufacturing and supply of COVID-19 vaccines and drugs Court Rules on Supply of AstraZeneca’s...

Bristol-Myers Squibb (BMS) and Eisai have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization of Eisai’s MORAb-202, an antibody drug conjugate (ADC), in a $3.1-billion deal ($645...

Elanco Animal Health, the former animal-health business of Eli Lilly and Company and now a stand-alone company, has agreed to sell two manufacturing sites in Shawnee, Kansas, and Speke, UK to Tris Pharmaceuticals, a Norwalk, Connecticut-based CDMO....

Bayer is investing EUR 250 million ($303 million) to build a new pharmaceutical plant and concurrently modernize its existing production plant in Turku, Finland. The new production plant will be built on an existing building in Artukais, Turuk,...